Terms: = Germ cell tumor AND CD52, CDW52, EDDM5
5 results:
1. cd52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
de Vos-Hillebrand L; Fietz S; Hillebrand P; Kulcsár Z; Diop MY; Hollick S; Maas AP; Strieth S; Landsberg J; Dietrich D
Pigment Cell Melanoma Res; 2024 Mar; 37(2):309-315. PubMed ID: 37975535
[TBL] [Abstract] [Full Text] [Related]
2. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors.
Kreher MA; Konda S; Noland MMB; Longo MI; Valdes-Rodriguez R
J Am Acad Dermatol; 2023 Mar; 88(3):534-542. PubMed ID: 36460256
[TBL] [Abstract] [Full Text] [Related]
3. The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours.
Zhao Y; Li J; Ting KK; Chen J; Coleman P; Liu K; Wan L; Moller T; Vadas MA; Gamble JR
Cancer Lett; 2021 Jan; 496():1-15. PubMed ID: 32991950
[TBL] [Abstract] [Full Text] [Related]
4. Targeting Vascular Endothelial-Cadherin in tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy.
Zhao Y; Ting KK; Li J; Cogger VC; Chen J; Johansson-Percival A; Ngiow SF; Holst J; Grau G; Goel S; Muller T; Dejana E; McCaughan G; Smyth MJ; Ganss R; Vadas MA; Gamble JR
Cancer Res; 2017 Aug; 77(16):4434-4447. PubMed ID: 28655790
[TBL] [Abstract] [Full Text] [Related]
5. Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantations.
Tangnararatchakit K; Tirapanich W; Anurathapan U; Tapaneya-Olarn W; Pakakasama S; Jootar S; Slavin S; Hongeng S
Pediatr Transplant; 2012 Dec; 16(8):E342-7. PubMed ID: 22553996
[TBL] [Abstract] [Full Text] [Related]
